Handelsavisen
prelaunch
Companies Healthcare 8769.T
87
8769.T Tokyo Stock Exchange Healthcare Facilities & Services

Advantage Risk Management Co Ltd

¥468,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
3,33 %
Op margin
22,1 %
ROE
7,8 %
Net margin
15,5 %
Debt / equity
0,09
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Advantage Risk Management Co Ltd provides healthcare services and equipment, primarily generating revenue through service provision and product sales.

Business. Advantage Risk Management Co Ltd (8769.T) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic presence are not disclosed.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
7,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 8769.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 8769.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Advantage Risk Management Co Ltd (8769.T) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic presence are not disclosed.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    The company maintains a strong liquidity position, with a current ratio of 1.29 and cash and equivalents amounting to 1,428,867,000 JPY. This liquidity is supported by a low debt-to-equity ratio of 0.09, indicating a conservative capital structure.

    Profitability metrics show a return on equity of 7.79% and a return on assets of 4.74%, which are in line with the industry's preferred metrics. The operating income of 442,585,000 JPY and net income of 310,234,000 JPY reflect a healthy margin, suggesting efficient operations.

    The company's revenue is primarily concentrated in its core healthcare services and equipment segment, with no significant geographic diversification disclosed. This concentration may pose a risk if the core market experiences downturns.

    Looking ahead, the company is projected to maintain its growth trajectory, with a positive outlook for the current and next fiscal years. The operating cash flow of 1,292,086,000 JPY supports this growth, although capital expenditures of -876,246,000 JPY indicate ongoing investment in infrastructure.

    Risk factors are minimal, with low liquidity and dilution risks identified. There are no immediate filing-based liquidity or dilution flags, and the dilution potential is low. The company's conservative capital structure and strong cash reserves further mitigate these risks.

    Recent events, including the latest financial filings and transcripts, do not indicate any significant changes in the company's strategic direction or operational performance. The company continues to focus on its core healthcare services and equipment segment.

    Key takeaways
    • Advantage Risk Management Co Ltd has a strong liquidity position with a current ratio of 1.29 and significant cash reserves.
    • The company's profitability metrics, including a return on equity of 7.79%, are in line with industry standards.
    • Revenue is primarily concentrated in the healthcare services and equipment segment, with no significant geographic diversification.
    • The company is projected to maintain its growth trajectory, supported by a positive operating cash flow.
    • Risk factors are minimal, with low liquidity and dilution risks identified.
    • **margin_outlook_rationale**: The company's operating margin is expected to remain stable due to efficient cost management and strong demand for healthcare services.
    • **rd_outlook_rationale**: Research and development expenditures are not disclosed, but the company's focus on healthcare services suggests ongoing innovation.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Revenue grew 22.2% year-over-year to JPY 8.55 billion in fiscal 2025, demonstrating strong top-line expansion momentum.

    Net income surged 47.2% to JPY 744 million, significantly outpacing revenue growth and indicating robust operational leverage.

    Operating margin of 22.1% ranks above the 75th percentile of the Healthcare Facilities & Services cohort median.

    Free cash flow improved dramatically by 391.5% to JPY 642 million, marking a strong turnaround from previous deficits.

    Cash conversion ratio of 4.16 is best-in-class compared to the cohort median of 1.35, highlighting superior efficiency.

    BEAR CASE · 3

    Long-term debt increased sharply to JPY 1.97 billion in fiscal 2025, a significant rise from JPY 345 million prior.

    Operating income growth of 8.6% lagged significantly behind the 22.2% revenue growth rate in the latest fiscal year.

    Return on assets of 4.74% indicates relatively low asset utilization efficiency compared to the high margin profile.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-02-13
    Q4 2025 · Quarter highlights

    Revenue ¥2.66B, +3,9% YoY; Operating income −21,6% YoY.

    Revenue¥2.66B+3,9 % YoY
    Operating income¥351.3M−21,6 % YoY
    Net income¥246.0M−19,0 % YoY
    Free cash flow
    EPS
    Operating cash flow
    Financials
    Income statement
    Revenue¥2.66B
    Gross profit¥1.76B
    Operating income¥351.3M
    Net income¥246.0M
    Margins
    Gross margin65.9%
    Operating margin13.2%
    Net margin9.2%
    FCF margin
    Balance sheet
    Total assets¥8.62B
    Total liabilities¥4.45B
    Total equity¥4.17B
    Cash & equivalents¥2.00B
    Long-term debt¥1.60B
    P&L flow · revenue → net income
    Revenue ¥2.66BOperating costs ¥2.31BTax ¥105.3MNet income ¥246.0M
    Highlights
    • Revenue ¥2.66B, +3,9% YoY
    • Operating income −21,6% YoY
    • Net income −19,0% YoY
    • Net margin 9.2%

    Valuation TTM

    Market price
    ¥468,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    ¥3.98B
    Net cash
    ¥1.08B
    Current ratio
    1.3
    Debt / equity
    0.1
    ROA
    4.7%
    ROE
    7.8%
    Cash conversion
    416.0%
    CapEx / revenue
    -43.9%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin22,1 %Above P75
    Net Margin15,5 %Above P75
    ROE7,8 %Above median
    Capex / Rev-43,9 %Bottom quartile
    D/E0,09Above median
    Cash Conv4,16Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Advantage Risk Management Co Ltd Market data — financials · 2026-05-27
    • Advantage Risk Management Co Ltd Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    8769.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-02-13 08:14 UTCEARNINGSQuarterly results — Q4 2025 Revenue JPY 2.66B · Net JPY 246.0M
    2025-11-13 12:00 UTCEARNINGSQuarterly results — Q3 2025 Revenue JPY 2.32B · Net JPY 89.5M
    2025-08-13 12:00 UTCEARNINGSQuarterly results — Q2 2025 Revenue JPY 2.24B · Net JPY 97.2M
    2025-05-15 12:00 UTCEARNINGSQuarterly results — Q1 2025 Revenue JPY 2.63B · Net JPY 566.0M
    2025-05-15 12:00 UTCEARNINGSAnnual results — FY 2025 Revenue JPY 8.55B · Net JPY 744.4M
    2025-02-14 12:00 UTCEARNINGSQuarterly results — Q4 2024 Revenue JPY 2.56B · Net JPY 303.9M
    2024-11-14 12:00 UTCEARNINGSQuarterly results — Q3 2024 Revenue JPY 1.72B · Net JPY -162.5M
    2024-08-09 12:00 UTCEARNINGSQuarterly results — Q2 2024 Revenue JPY 1.64B · Net JPY 37.0M
    2024-05-14 12:00 UTCEARNINGSQuarterly results — Q1 2024 Revenue JPY 2.00B · Net JPY 310.2M
    2024-05-14 12:00 UTCEARNINGSAnnual results — FY 2024 Revenue JPY 7.00B · Net JPY 505.6M
    2023-05-12 12:00 UTCEARNINGSAnnual results — FY 2023 Revenue JPY 6.41B · Net JPY 377.6M
    2022-05-13 12:00 UTCEARNINGSAnnual results — FY 2022 Revenue JPY 5.79B · Net JPY 201.8M
    2021-05-14 12:00 UTCEARNINGSAnnual results — FY 2021 Revenue JPY 5.45B · Net JPY 496.2M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage